Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - AUDIOEYE INCtv499735_ex32-1.htm
EX-31.1 - EXHIBIT 31.1 - AUDIOEYE INCtv499735_ex31-1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2018

 

¨TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from [                     ] to [                     ]

 

Commission file number 333-177463 

 

 

AudioEye, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   20-2939845
(State or other jurisdiction of incorporation or
organization)
  (I.R.S. Employer Identification No.)
     
5210 East Williams Circle, Suite 750,
Tucson, Arizona
  85711
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code:  866-331-5324

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the last 90 days. Yes x   No ¨

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x     No ¨

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨ Accelerated filer ¨
Non-accelerated filer ¨ Smaller reporting company x
Emerging growth company ¨    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

 

As of August 14, 2018, 7,479,775 shares of the registrant’s common stock were issued and outstanding.

 

 

 

   

 

 

    Page
     
PART I FINANCIAL INFORMATION  
     
Item 1. Financial Statements  
     
  Consolidated Balance Sheets as of June 30, 2018 and December 31, 2017 (unaudited) 3
     
  Consolidated Statements of Operations for the three and six months ended June 30, 2018 and 2017 (unaudited) 4
     
  Consolidated Statement of Stockholders’ Equity for six months ended June 30, 2018 (unaudited) 5
     
  Consolidated Statements of Cash Flows for the six months ended June 30, 2018 and 2017 (unaudited) 6
     
  Notes to Consolidated Financial Statements (unaudited) 7
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 18
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 25
     
Item 4. Controls and Procedures 25
     
PART II OTHER INFORMATION  
     
Item 1. Legal Proceedings 25
     
Item 1A. Risk Factors 26
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 26
     
Item 3. Defaults Upon Senior Securities 26
     
Item 4. Mine Safety Disclosures 26
     
Item 5. Other Information 26
     
Item 6. Exhibits 27
     
SIGNATURES 28

 

   

 

  

PART I — FINANCIAL INFORMATION

 

Item 1.  Financial Statements

 

AUDIOEYE, INC.

CONSOLIDATED BALANCE SHEETS

 

   June 30,   December 31, 
   2018   2017 
   (unaudited)     
ASSETS          
Current assets:          
Cash  $679,590   $1,960,430 
Accounts receivable   257,733    105,817 
Marketable securities, held in related party   2,400    750 
Deferred costs, short term   61,221    - 
Prepaid expenses and other current assets   68,574    67,406 
Total current assets   1,069,518    2,134,403 
           
Property and equipment, net   94,806    34,994 
           
Deferred costs, long term   59,765    - 
Intangible assets, net   2,084,732    2,164,463 
Goodwill   700,528    700,528 
           
Total assets  $4,009,349   $5,034,388 
           
LIABILITIES AND STOCKHOLDERS' EQUITY          
Current liabilities:          
Accounts payable and accrued expenses  $84,756   $82,628 
Related party payables   14,467    23,535 
Derivative liabilities   -    2,984,010 
Capital leases, short term   19,110    - 
Deferred rent   4,260    9,402 
Deferred revenue   1,697,266    1,233,754 
Total current liabilities   1,819,859    4,333,329 
           
Long term liabilities:          
Capital leases, long term   40,104    - 
Deferred rent   8,325    5,048 
           
Total liabilities   1,868,288    4,338,377 
           
Stockholders' equity:          
Preferred stock, $0.00001 par value, 10,000,000 shares authorized          
Series A Convertible Preferred stock, $0.00001 par value, 200,000 shares Designated, 105,000 and 110,000 shares issued and outstanding as of June 30, 2018 and December 31, 2017, respectively   1    1 
Common stock, $0.00001 par value, 50,000,000 shares authorized, 6,487,779 and 6,466,564 shares issued and outstanding as of June 30, 2018 and December 31, 2017 respectively   65    65 
Additional paid in capital   41,521,360    40,121,845 
Accumulated deficit   (39,380,365)   (39,425,900)
Total stockholders' equity   2,141,061    696,011 
           
Total liabilities and stockholders' equity  $4,009,349   $5,034,388 

 

See Notes to Unaudited Consolidated Financial Statements

 

 3 

 

  

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)

 

   Three months ended June 30,   Six months ended June 30, 
   2018   2017   2018   2017 
Revenues  $1,234,897   $684,224   $2,384,239   $1,118,731 
                     
Cost of revenue   622,645    440,033    1,210,109    781,075 
                     
Gross profit   612,252    244,191    1,174,130    337,656 
                     
Operating expenses:                    
Selling and marketing   576,894    337,156    1,187,556    616,883 
Research and development   49,362    49,267    99,029    93,969 
General and administrative   944,428    615,528    1,881,388    1,353,209 
Amortization and depreciation   137,412    147,921    265,077    293,409 
Total operating expenses   1,708,096    1,149,872    3,433,050    2,357,470 
                     
Operating loss   (1,095,844)   (905,681)   (2,258,920)   (2,019,814)
                     
Other income (expense):                    
Unrealized loss on derivative liabilities   -    (1,264,962)   -    (954,189)
Unrealized gain on marketable securities   1,422    -    1,650    - 
Interest income (expense), net   (105)   (48,284)   132    (48,120)
Total other income   1,317    (1,313,246)   1,782    (1,002,309)
                     
Net loss   (1,094,527)   (2,218,927)   (2,257,138)   (3,022,123)
                     
Dividends on Series A Convertible preferred stock   (13,524)   (20,000)   (27,274)   (40,000)
                     
Net loss available to common stockholders  $(1,108,051)  $(2,238,927)  $(2,284,412)  $(3,062,123)
                     
Net loss per common share-basic and diluted  $(0.17)  $(0.50)  $(0.35)  $(0.68)
                     
Weighted average common shares outstanding-basic and diluted   6,471,832    4,494,859    6,469,212    4,485,164 

 

See Notes to Unaudited Consolidated Financial Statements

 

 4 

 

 

AUDIOEYE, INC.

CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY

SIX MONTHS ENDED JUNE 30, 2018

(unaudited)

 

                   Additional         
   Common stock   Preferred stock   Paid in   Accumulated     
   Shares   Amount   Shares   Amount   Capital   Deficit   Total 
Balance, December 31, 2017   6,466,564   $65    110,000   $1   $40,121,845   $(39,425,900)  $696,011 
Common stock issued upon conversion of preferred stock   13,204    -    (5,000)   -    -    -    - 
Common stock issued in exchange for exercise of warrants on a cashless basis   5,842    -    -    -    -    -    - 
Common stock issued in exchange for exercise of options on a cashless basis   2,169    -    -    -    -           
Effect of adoption of Accounting Codification Standard 2014-09, Revenue from Contracts with Customers   -    -    -    -    -    80,153    80,153 
Reclassify derivative liability to equity upon adoption of Accounting Codification Standard 2017-11, Earnings Per Share   -    -    -    -    761,490    2,222,520    2,984,010 
Restricted stock units, warrants and options issued for services   -    -    -    -    638,025    -    638,025 
Net loss   -    -    -    -    -    (2,257,138)   (2,257,138)
Balance, June 30, 2018   6,487,779   $65    105,000   $1   $41,521,360   $(39,380,365)  $2,141,061 

 

See Notes to Unaudited Consolidated Financial Statements

 

 5 

 

 

AUDIOEYE, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(unaudited)

 

   Six months ended June 30, 
   2018   2017 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net (loss)  $(2,257,138)  $(3,022,123)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   265,077    293,409 
Amortization of debt discounts   -    7,326 
Bad debt expense   -    358 
Non cash interest expense associated with derivative warrants   -    39,944 
Option, warrant, RSU and PSU expense   638,025    571,316 
Stock issued for services   -    25,001 
Unrealized gain on marketable securities   (1,650)   - 
Change in fair value of derivative liabilities   -    954,189 
Amortization of deferred commission   25,491    - 
Changes in operating assets and liabilities:          
Accounts receivable   (151,916)   (209,667)
Deferred costs   (66,324)   - 
Other current assets   (1,168)   (4,927)
Accounts payable and accruals   2,128    (140,937)
Deferred rent   (1,865)   (770)
Deferred revenue   463,512    465,565 
Related party payables   (9,068)   - 
Net cash (used in) operating activities   (1,094,896)   (1,021,316)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchase of equipment   (10,893)   (16,255)
Software development costs   (173,597)   (50,970)
Net cash (used in) investing activities   (184,490)   (67,225)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Issuance of common stock and warrants for cash   -    50,000 
Issuance of convertible note payable   -    50,000 
Repayments of notes payable and capital leases   (1,454)   (12,000)
Net cash provided by (used in) financing activities   (1,454)   88,000 
           
Net decrease in cash   (1,280,840)   (1,000,541)
Cash-beginning of period   1,960,430    1,409,418 
Cash-end of period  $679,590   $408,877 
           
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION          
Interest paid  $255   $- 
Income taxes paid  $-   $- 
           
Non cash investing and financing activities:          
Reclassify fair value of liability warrants from equity to liability upon issuance  $-   $6,062 
Reclassify fair value of liability warrants from liability to equity upon exercise  $-   $184,569 
Debt discount originated from derivative feature of warrants attached to note  $-   $50,000 
Restricted stock units issued in payment of accrued compensation  $-   $14,583 
Equipment acquired from capital leases  $60,668   $- 
Reclassify fair value of warrant liabilities to equity upon adoption of ASU 2017-11  $2,984,010   $- 
Effect of adoption of Accounting Codification Standard 2014-09, Revenue from Contracts with Customers  $80,153   $- 

 

See Notes to Unaudited Consolidated Financial Statements

 

 6 

 

 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

NOTE 1: ORGANIZATION AND BASIS OF PRESENTATION

 

The accompanying unaudited interim financial statements of AudioEye, Inc. and its wholly-owned subsidiary (collectively, the “Company”) have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules of the Securities and Exchange Commission, and should be read in conjunction with the audited financial statements and notes thereto contained in the Company’s Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 2, 2018.

 

In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the interim periods presented have been reflected herein. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. Notes to the financial statements that would substantially duplicate the disclosures contained in the audited financial statements for the year ended December 31, 2017 as reported in the Company’s Annual Report on Form 10-K have been omitted.

 

On August 1, 2018, the Company amended its Articles of Incorporation to implement a reverse stock split in the ratio of 1 share for every 25 shares of common stock and to reduce the number of authorized common stock from 250,000,000 to 50,000,000. As a result, 186,994,384 shares of the Company’s common stock were exchanged for 7,479,775 shares of the Company's common stock. These financial statements have been retroactively restated to reflect the reverse stock split. (See Note 8)

 

Revenue Recognition

 

The Company recognizes revenue when delivery of the promised goods or services is transferred to its customers, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services.

 

Certain Software as a Service (SaaS) are prepared and invoiced on an annual basis. Any funds received for services not provided yet are held in deferred revenue, and are recorded as revenue when earned.

 

The Company had one major customer including their affiliates which generated approximately 9% and 11% of its revenue in the three and six months ended June 30, 2018, respectively.

 

At June 30, 2018, the Company had three customers representing 28.5%, 16.0% and 13.1%, aggregate of 57.6% of the outstanding accounts receivable.

 

Effective January 1, 2018, the Company adopted ASU 2014-09, Revenue from Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific revenue recognition guidance throughout the Industry Topics of the Accounting Standards Codification. The updated guidance states that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also provides for additional disclosures with respect to revenues and cash flows arising from contracts with customers. The Company adopted the standard using the modified retrospective approach effective January 1, 2018.

 

 7 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

The most significant impact of the standard relates to capitalizing costs to acquire contracts, which have historically been expensed as incurred. As of December 31, 2017, the Company’s sales commission plans have included multiple payments, including initial payments in the period a customer contract is obtained and deferred payments over the life of the contract as future payments are collected from the customers. Under the standard, only the initial payment is subject to capitalization as the deferred payments require a substantive performance condition of the employee. These initial commission payments are now capitalized in the period a customer contract is obtained and payment is received; and will be amortized consistent with the transfer of the goods or services to the customer over the expected period of benefit. The expected period of benefit is the contract term, except when the commission payment is expected to provide economic benefit to the Company for a period longer than the contract term, such as for new customer or incremental sales where renewals are expected and renewal commissions are not commensurate with initial commissions. Such commissions are amortized over the greater of contract term or technological obsolescence period when the underlying contracted products are technology-based, such as for the SaaS-based platforms, or the expected customer relationship period when the underlying contracted products are not technology-based, such as for patient experience survey products. Upon adoption of Topic 606, the Company reclassified $80,153 from equity previously expensed commissions to deferred costs effective January 1, 2018. There were significant changes in contract liabilities balances during the six months ended June 30, 2018. Deferred Revenue increased to $1,697,266 at June 30, 2018 compared to $1,233,754 at December 31, 2017 due to cash received of $2,172,458 less revenue recognized of $1,708,946. 

 

Effects of adoption of ASU 2014-09 are as follows:

 

   At January 1, 2018:     
   Prior to adoption of
ASU 2014-09
   Subsequent to
adoption of ASU
2014-09
   Change 
Accumulated deficit  $(39,425,900)  $(39,345,747)  $(80,153)
Deferred commission cost  $-   $80,153   $80,153 

   

Derivative Instrument Liability

 

The Company accounts for derivative instruments in accordance with ASC 815, which establishes accounting and reporting standards for derivative instruments and hedging activities, including certain derivative instruments embedded in other financial instruments or contracts and requires recognition of all derivatives on the balance sheet at fair value, regardless of hedging relationship designation. Accounting for changes in fair value of the derivative instruments depends on whether the derivatives qualify as hedging relationships and the types of relationships designated are based on the exposures hedged. At June 30, 2018 and December 31, 2017, the Company did not have any derivative instruments that were designated as hedges.

 

In 2017 and prior and in accordance with ASC 815, certain warrants with anti-dilutive provisions were deemed to be derivatives. The value of the derivative instrument will fluctuate with the price of the Company’s common stock and is recorded as a current liability on the Company’s Consolidated Balance Sheet. The change in the value of the liability is recorded as “unrealized gain (loss) on derivative liability” on the Consolidated Statements of Operations.

 

Effective January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480), Derivatives and Hedging (Topic 815). The amendments in Part I of this Update change the classification analysis of certain equity-linked financial instruments (or embedded features) with down round features.

 

 8 

 

 

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

When determining whether certain financial instruments should be classified as liabilities or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. The amendments also clarify existing disclosure requirements for equity-classified instruments. As a result, a freestanding equity-linked financial instrument (or embedded conversion option) no longer would be accounted for as a derivative liability at fair value as a result of the existence of a down round feature. For freestanding equity classified financial instruments, the amendments require entities that present earnings per share (EPS) in accordance with Topic 260 to recognize the effect of the down round feature when it is triggered. That effect is treated as a dividend and as a reduction of income available to common shareholders in basic EPS. Convertible instruments with embedded conversion options that have down round features are now subject to the specialized guidance for contingent beneficial conversion features (in Subtopic 470-20, Debt—Debt with Conversion and Other Options), including related EPS guidance (in Topic 260). The amendments in Part II of this Update recharacterize the indefinite deferral of certain provisions of Topic 480 that now are presented as pending content in the Codification, to a scope exception.

 

On January 1, 2018, the Company adopted ASU 2017-11 by electing the modified retrospective method to the outstanding financial instruments with a down round feature by means of a cumulative-effect adjustment to the statement of financial position as of the beginning of the fiscal year. Accordingly, the Company reclassified the fair value of the reset provisions embedded in previously issued warrants from liability to equity (accumulated deficit) in aggregate of $2,984,010.

 

Effects of adoption of ASU 2017-11 modified retrospective are as follows:

 

   At January 1, 2018:     
   Prior to adoption of
ASU 2014-09
   Subsequent to
adoption of ASU
2014-09
   Change 
Derivative liabilities  $2,984,010   $-   $(2,984,010)
Additional paid in capital   40,120,293    40,881,783    761,490 
Accumulated deficit  $(39,425,900)  $(37,203,380)  $2,222,520 

  

Earnings (Loss) Per Share

 

Basic earnings (loss) per share are computed by dividing net income, or loss, by the weighted average number of shares of common stock outstanding for the period. Diluted earnings (loss) per share and basic earnings (loss) per share are not included in the net loss per share computation until the Company has Net Income. Diluted loss per share including the dilutive effects of common stock equivalents on an “as if converted” basis would reduce the loss per share and thereby be antidilutive.

 

Potentially dilutive securities excluded from the computation of basic and diluted net earnings (loss) per share are as follows:

 

  

June 30,

2018

  

June 30,

2017

 
Preferred stock   277,371    404,492 
Options to purchase common stock   1,062,609    1,007,083 
Warrants to purchase common stock   1,766,122    2,524,922 
Restricted stock units   194,672    103,339 
Totals   3,300,774    4,039,836 

 

 9 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

Fair Value Measurements

 

Fair value is an estimate of the exit price, representing the amount that would be received to upon the sale of an asset or paid to transfer a liability in an orderly transaction between market participants (i.e., the exit price at the measurement date). Fair value measurements are not adjusted for transaction cost. Fair value measurement under generally accepted accounting principles provides for use of a fair value hierarchy that prioritizes inputs to valuation techniques used to measure fair value into three levels:

 

Level 1: Unadjusted quoted prices in active markets for identical assets or liabilities.

 

Level 2: Inputs other than quoted market prices that are observable, either directly or indirectly, and reasonably available. Observable inputs reflect the assumptions market participants would use in pricing the asset or liability and are developed based on market data obtained from sources independent of the Company.

 

Level 3: Unobservable inputs reflect the assumptions that the Company develops based on available information about what market participants would use in valuing the asset or liability.

 

An asset or liability’s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement. Availability of observable inputs can vary and is affected by a variety of factors. The Company uses judgment in determining fair value of assets and liabilities and Level 3 assets and liabilities involve greater judgment than Level 1 and Level 2 assets or liabilities.

 

The following are the Company’s assets and liabilities, measured at fair value on a recurring basis, as of June 30, 2018 and December 31, 2017:

 

          Fair Value  
    Fair Value     Hierarchy  
Assets                
Marketable securities, June 30, 2018   $ 2,400       Level 1  
Marketable securities, December 31, 2017   $ 750       Level 1  
                 
Liabilities                
Derivative Liability ,June 30, 2018   $ -       Level 3  
Derivative Liability , December 31, 2017   $ 2,984,010       Level 3  

 

Recent Accounting Pronouncements

 

There are various updates recently issued, most of which represented technical corrections to the accounting literature or application to specific industries and are not expected to a have a material impact on the Company's financial position, results of operations or cash flows.

 

NOTE 2 – MANAGEMENT’S LIQUIDITY PLANS

 

As of June 30, 2018, the Company had cash of $679,590 and a working capital deficit of $750,341. In addition, the Company used actual net cash in operations of $1,094,896 during the six months ended June 30, 2018. 

 

On August 6, 2018, the Company sold 992,000 shares of its common stock at $6.25 per share for net proceeds of $5,547,635, after costs and expenses of $652,365 In addition, the Company has received common stock subscriptions for 48,000 shares of its common stock at a sales price of $6.25 per share for net proceeds of $288,000, after costs and expenses of $12,000. It is anticipated that the Company has cash sufficient to fund operations for the next twelve months (See Note 10).

 

 10 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

NOTE 3 — PROPERTY AND EQUIPMENT

 

Property and equipment as of June 30, 2018 and December 31, 2017 is summarized as follows:

 

   June 30,
2018
   December 31,
2017
 
Computer equipment  $72,570   $63,517 
Equipment under capital lease   60,668    - 
Furniture and fixtures   4,968    3,128 
Total   138,206    66,645 
Less accumulated depreciation   (43,400)   (31,651)
Property and equipment, net  $94,806   $34,994 

 

Property and equipment are stated at cost and depreciated using the straight-line method over their estimated useful life of 3 years. When retired or otherwise disposed, the related carrying value and accumulated depreciation are removed from the respective accounts and the net difference less any amount realized from disposition, is reflected in earnings.

 

Included in net property are assets under capital leases of $60,668, less accumulated depreciation of $3,115 as of June 30, 2018 and $0, less accumulated depreciation of $0 as of December 31, 2017, respectively.

 

The Company spent $10,893 in purchases and leased $60,668 of equipment during the six months ended June 30, 2018 and $16,255 in purchases of equipment during the six months ended June 30, 2017. Depreciation expense was $7,432 and $11,749 for the three and six months ended June 30, 2018; and $814 and $1,261 for the three and six months ended June 30, 2017.

 

NOTE 4 — INTANGIBLE ASSETS

 

For the six months ended June 30, 2018 and 2017, the Company invested in software development costs in the amounts of $173,597 and $50,970 respectively.

 

Patents, technology and other intangibles with contractual terms are generally amortized over their estimated useful lives of ten years. When certain events or changes in operating conditions occur, an impairment assessment is performed and lives of intangible assets with determinable lives may be adjusted.

 

Software development costs are amortized over their estimated useful life of three years.

 

Prior to any impairment adjustment, intangible assets consisted of the following:

 

   June 30,
2018
   December 31,
2017
 
Patents  $3,697,709   $3,697,709 
Capitalized software development   1,178,966    1,005,369 
Accumulated amortization   (2,791,943)   (2,538,615)
Intangible assets, net  $2,084,732   $2,164,463 

 

Amortization expense for patents totaled $93,658 and $180,684 for the three and six months ended June 30, 2018, respectively; and $93,648 and $185,230 for the three and six months ended June 30, 2017, respectively. Amortization expense for software development totaled $36,322 and $72,644 for the three and six months ended June 30, 2018, respectively; and $53,459 and $106,918 for the three and six months ended June 30, 2017, respectively.

 

 11 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

Total amortization expense totaled $253,328 and $292,148 for the six months ended June 30, 2018 and 2017, respectively.

 

NOTE 5 — DEFERRED COSTS

 

Effective January 1, 2018, the Company capitalizes initial and renewal sales commission payments in the period a customer contract is obtained and payment is received; and is amortized consistent with the transfer of the goods or services to the customer over the expected period of benefit. The expected period of benefit is the contract term, except when the commission payment is expected to provide economic benefit to the Company for a period longer than the contract term, such as for new customer or incremental sales where renewals are expected and renewal commissions are not commensurate with initial commissions.

 

Such commissions are amortized over the greater of contract term or technological obsolescence period when the underlying contracted products are technology-based, such as for the SaaS-based platforms, or the expected customer relationship period when the underlying contracted products are not technology-based, such as for patient experience survey products.

 

During the six months ended June 30, 2018, the Company deferred an aggregate $66,324 commissions paid and reclassified from equity $80,153 previously paid and expensed commissions. Amortization of deferred costs for the three and six months ended June 30, 2018 was $15,517 and $25,491.

 

NOTE 6 — CAPITAL LEASES

 

  

June 30,

2018

  

December 31,

2017

 
Capital equipment lease dated April 5, 2018  $15,625   $- 
Capital equipment lease dated May 8, 2018   17,850    - 
Capital equipment lease dated June 27, 2018   25,739    - 
Total capital leases payable   59,214    - 
Less current portion   (19,110)   - 
Long term portion  $40,104   $- 

 

During the six months ended June 30, 2018, the Company entered into three capital leases for computer equipment for a three year term.  The Company recognized these arrangements as a capital leases based on the determination the leases exceeded 75% of the economic life of the underlying assets.  The Company initially recorded the equipment and the capitalized lease liability at the estimated present value of the minimum lease payments of $60,668. 

 

The leases include base monthly payments in aggregate of $1,839, due on the contract monthly anniversary of each calendar month.  At the expiration of the lease, the Company is required to return all leased equipment to the lessor with right of repurchase at fair value.

 

The Company determined that the capital leases exceeded 75% of the estimated economic life of the equipment and therefore classified as a capitalized leases. The effective interest rate of the capitalized lease is estimated at 6.00% based on the Company estimated incremental borrowing rate.

 

 12 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

The following summarizes the assets under capital leases:

 

  

June 30,

2018

  

December 31,

2017

 
Classes of property          
Computer equipment   60,668    - 
Less: accumulated depreciation   (3,115)   - 
   $57,553   $- 

 

The following summarizes total future minimum lease payments at June 30, 2018:

 

Period ending December 31,    
Six months ended December 31, 2018  $11,108 
2019   22,066 
2020   22,066 
2021   9,474 
Total minimum lease payments   64,714 
Amount representing interest   5,500 
Present value of minimum lease payments   59,214 
Current portion of capital lease obligations   19,110 
Capital lease obligation, less current portion  $40,104 

 

NOTE 7 — RELATED PARTY TRANSACTIONS

 

Dr. Carr Bettis, Executive Chairman and Chairman of Board of Directors

 

As of June 30, 2018 and December 31, 2017, the Company owed Dr. Bettis $5,992 in accrued salary. In addition, AudioEye sub-leases office space in Scottsdale, Arizona for certain Company employees, including Todd Bankofier, CEO, from Verus Analytics, Inc, a company in which Dr. Bettis has a controlling interest. As the Company has taken on more employees and space, the sub-lease amount increased from $500 per month to $3,502 per month in 2017 totaling $10,506 and $21,013 for the three and six months ended June 30, 2018; and $3,252 and $4,752 for the three and six months ended June 30, 2017, respectively. The amount of $0 was due as of June 30, 2018 and December 31, 2017. At June 30, 2018 and December 31, 2017, an estimated $8,475 and $14,000 was due and accrued to Dr. Bettis for unreimbursed travel related expenses, respectively.

 

Sean Bradley, President, Chief Technology Officer, and Secretary

 

As of June 30, 2018 and December 31, 2017, the Company owed Sean Bradley $0 and $3,543 in accrued salary, respectively.

 

NOTE 8 — STOCKHOLDERS’ EQUITY

 

On August 1, 2018, the Company amended its Articles of Incorporation to implement a reverse stock split in the ratio of 1 share for every 25 shares of common stock and to reduce the number of authorized common stock from 250,000,000 to 50,000,000. No fractional shares were issued from such aggregation of common stock, upon the reverse split; any fractional share was rounded up and converted to the nearest whole share of common stock. As a result, 186,994,384 of the Company’s common stock were exchanged for 7,479,775 of the Company's common stock resulting in the transfer of $1,795 from common stock to additional paid in capital. These amendments were approved and filed of record by the Delaware Secretary of State on August 1, 2018, effective on August 1, 2018.  FINRA declared the Company’s 1-for-25 reverse stock split market effective as of August 8, 2018. These financial statements have been retroactively restated to reflect the reverse stock split.

 

 13 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

Preferred stock

 

As of June 30, 2018 and December 31, 2017, the Company had 105,000 and 110,000 shares of Series A Convertible Preferred Stock, respectively, issued at $10 per share, paying a 5% cumulative annual dividend and convertible for common stock at a price of $4.385 per share, as adjusted for the Company’s reverse stock split. For the six months ended June 30, 2018, preferred shareholders earned, but were not paid $27,274 in annual dividends, or equivalent to 6,220 common shares based on a conversion price of $4.385 per share. As of June 30, 2018 and December 31, 2017, cumulative and unpaid dividends were $166,274 and $146,918, or equivalent to 37,919 and 33,505 common shares based on a conversion price of $4.385 per share, respectively.

 

Common stock

 

As of June 30, 2018 and December 31, 2017 on a post-split basis, the Company had 6,487,779 and 6,466,564 shares of common stock issued and outstanding, respectively.

 

In April 2018, the Company issued 5,842 shares of its common stock upon the cashless exercise of outstanding warrants to purchase 127,525 shares of common stock.

 

In June 2018, the Company issued 2,169 shares of its common stock upon the cashless exercise of outstanding options to purchase 8,667 shares of common stock.

 

In June 2018, the Company issued 13,204 shares of its common stock upon conversion of 5000 shares of Series A Convertible Preferred Stock and accrued dividends.

 

Options

 

As of June 30, 2018 and December 31, 2017, the Company has outstanding options to purchase 1,062,609 and 1,003,836 shares of common stock, respectively.

 

                   Intrinsic 
           Wtd Avg.       Value 
   Number of   Wtd Avg.   Remaining       of 
   Options   Exercise Price   Term   Exercisable   Options 
Outstanding at December 31, 2017   1,003,836   $4.69    2.64    891,087   $1,356,188 
Granted   73,440    6.32    5.00         - 
Exercised   (8,667)   3.88                
Forfeited/Expired   (6,000)   10.00                
Outstanding at June 30, 2018   1,062,609   $4.78    2.53    943,407   $3,232,212 

 

On March 9, 2018, the Company granted an aggregate of 60,390 options to employees as compensation for services rendered. The options are exercisable at $6.45 per share for five years with (i) 37,890 options vesting 50% at the first day of each month beginning January 1, 2018 through December 1, 2018, 25% vesting at the first day of each month from January 1, 2019 through December 1, 2019 and 25% vesting at the first day of each month beginning January 1, 2020 through December 1, 2020; (ii) 12,500 options vesting 50% on January 1, 2018, 50% vesting at each month beginning on January 1, 2019 for 24 months; and (iii) 10,000 options fully vesting on January 1, 2018. The exercise price was determined using the 10-day average closing price beginning with the closing price on January 9, 2018. The value on the grant date of the options was $298,914.

 

On April 12, 2018, the Company granted 6,000 options to purchase the Company’s common stock for services rendered at an exercise price of $6.20 per share for five years with 2,000 options vesting immediately and 1,000 options vesting every 90 days thereafter. The exercise price was determined using the 10-day average closing price beginning with the closing price on March 12, 2018. The value on the grant date of the options was $29,694.

 

 14 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

On May 31, 2018, the Company granted an aggregate of 7,050 options to employees as compensation for services rendered. The options are exercisable at $5.30 per share for five years with 50% of options vesting upon one year employee anniversary and 50% vesting at a rate of 1/24 per month thereafter. The exercise price was determined using the 10-day average closing price beginning with the closing price on May 16, 2018. The value on the grant date of the options was $33,130.

 

Option grants during the six months ended June 30, 2018 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 2.50 to 3.50 years, expected volatility of 160.87% to 163.85%, risk free interest rate of 2.45% to 2.65%, and expected dividend yield of 0%.

 

For the three and six months ended June 30, 2018 and 2017, total stock compensation expense related to the options totaled $78,152 and $223,198 and $257,619 and $425,033, respectively.

 

The outstanding unamortized stock compensation expense related to options was $248,727 (which will be recognized through December 2020) as of June 30, 2018.

 

Warrants

 

Below is a table summarizing the Company’s outstanding warrants as of June 30, 2018 and December 31, 2017:

 

               Intrinsic 
           Wtd Avg.   Value 
   Number of   Wtd Avg.   Remaining   of 
   Warrants   Exercise Price   Term   Warrants 
Outstanding at December 31, 2017   1,919,906   $4.98    2.61   $1,656,083 
Granted   127,525   $6.25           
Exercised   (127,525)               
Forfeited/Expired   (153,784)   6.66           
Outstanding at June 30, 2018   1,766,122   $4.84    2.32   $5,128,906 

 

On April 17, 2018, the Company granted 127,525 warrants for services rendered. The warrants are exercisable at $6.25 per share through May 16, 2018. The fair value of the warrants of $109,207 was charged to current operations.

 

Warrants issued during the six months ended June 30, 2018 were valued using the Black-Scholes pricing model. Significant assumptions used in the valuation include expected term of 0.08 years, expected volatility of 162.35%, risk free interest rate of 1.68%, and expected dividend yield of 0%.

 

For the three and six months ended June 30, 2018 and 2017, the Company has incurred warrant-based expense of $109,207 and $110,600 and $14,733 and $58,783, respectively. There was no outstanding unamortized stock compensation expense related to warrants as of June 30, 2018.

 

There was no outstanding unamortized stock compensation expense related to warrants as of June 30, 2018.

 

Restricted stock units (“RSU”)

 

The following table summarizes the restricted stock unit activity for the six months ended June 30, 2018:

 

Restricted stock units issued as of January 1, 2018   156,340 
Granted   38,334 
Total Restricted stock units issued at June 30, 2018   194,674 
Vested at June 30, 2018   151,408 
Unvested restricted stock units as of June 30, 2018   43,266 

 

 15 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

On March 27, 2018, the Company granted 38,334 RSUs, on a post-split basis, for services provided. 20,000 of such RSUs began vesting May 1, 2018, and will vest each calendar month at a rate of 1,667 RSUs per month, whereby the RSUs would vest provided that services are not terminated by the Company or the grantee. 18,333 RSU’s vested immediately. The settlement date for such RSUs is (i) April 1, 2025 or (ii) the date on which the Company undergoes a change of control during the seven-year term of the award. The fair value of the RSU’s at grant date was $247,250.

 

For the three and six months ended June 30, 2018 and 2017, the Company has incurred RSU-based expense of $83,363 and $304,227 and $87,500 and $87,500, respectively. The outstanding unamortized stock compensation expense related to RSUs was $96,200 (which will be recognized through April 2019) as of June 30, 2018.

 

NOTE 9 — COMMITMENTS AND CONTINGENCIES

 

Litigation

 

On January 23, 2017, the court granted preliminary approval of the settlement pursuant to the terms set forth in the Stipulation of Settlement, provisionally certified a settlement class of shareholders, and directed plaintiffs' counsel to provide notice to that class. The Court held a Settlement Hearing May 8, 2017 to consider any objections to the Settlement that might be raised by settlement class members, to consider plaintiffs’ counsel's application for an award of fees and costs, and to determine whether the Order and Final Judgment as provided under the Stipulation of Settlement should be entered, dismissing the case with prejudice. On May 8, 2017, this Court granted final approval to the settlement of the securities class action brought by Lead Plaintiffs, individually and on behalf of all others similarly situated. On February 9, 2018, the Court authorized distribution of the Net Settlement Fund and approved the proposed modified plan of allocation.

 

On May 16, 2016, a shareholder derivative complaint entitled LiPoChing, Derivatively and on Behalf of AudioEye, Inc., v. Bradley, et al., was filed in the United States District Court for the District of Arizona. As a derivative complaint, the plaintiff-shareholder purported to act on behalf of the Company against the Named Individuals. The Company was named as a nominal defendant. The complaint asserted causes of action including breach of fiduciary duty and others, arising from the Company’s restatement of its financial results for the first three quarters of 2014. The complaint sought, among other relief, compensatory damages, restitution and attorneys’ fees. In October 2016, the Company and Named Defendants filed a motion to dismiss. In response, the Plaintiff voluntarily dismissed the complaint without prejudice. Plaintiff’s counsel subsequently submitted a demand to the Company’s Board of Directors, to investigate the circumstances surrounding restatement of its financial results for the first three quarters of 2014. On June 22, 2018, the matter was resolved to the parties’ satisfaction. The resolution of the matter will not have a material adverse effect on our financial position or results of operations.

 

On July 26, 2016, a shareholder derivative complaint entitled Denese M. Hebert, derivatively on Behalf of Nominal Defendant AudioEye, Inc., v. Bradley, et al., was filed in the State of Arizona Superior Court for Pima County. The complaint generally asserted causes of action related to the Company’s restatement of its financial statements for the first three fiscal quarters of 2014. As a derivative complaint, the plaintiff-shareholder purported to act on behalf of the Company against the Named Individuals. The Company was named as a nominal defendant. The defendants filed a motion to dismiss, which the Court granted on May 8, 2017, while also denying Plaintiff’s request for leave to amend the complaint. As in the above matter, after this matter was dismissed Plaintiff’s counsel subsequently submitted a demand to the Company’s Board of Directors, to investigate the circumstances surrounding restatement of its financial results for the first three quarters of 2014. On June 22, 2018, the matter was resolved to the parties’ satisfaction. The resolution of the matter will not have a material adverse effect on our financial position or results of operations.

 

 16 

 

  

AUDIOEYE, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

June 30, 2018 (Unaudited)

 

We may become involved in various other routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.

 

NOTE 10 — SUBSEQUENT EVENTS

 

On August 6, 2018, the Company sold 992,000 shares of its common stock at $6.25 per share for net proceeds of $5,547,635, after costs and expenses of $652,365 In addition, the Company has received common stock subscriptions for 48,000 shares of its common stock at a sales price of $6.25 per share for net proceeds of $288,000, after costs and expenses of $12,000. It is anticipated that the Company has cash sufficient to fund operations for the next twelve months.

 

At the closing of the private placement, the Company also entered into a registration rights agreement (the “Registration Rights Agreement”) with the investors pursuant to which the Company agreed to register the shares for resale. Under the terms of the Registration Rights Agreement, the Company will be obligated to file a registration statement covering the resale or other disposition of the registrable securities by the Investors no later than 30 days after the initial closing and to use its reasonable best efforts to cause the registration statement to become effective no later than 90 days after the initial closing. In the event that the Company fails to file and obtain and maintain effectiveness of the registration statement, the Company is subject to certain penalties, including making certain registration delay payments to the investors.

 

 17 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations or MD&A, should be read in conjunction with our consolidated financial statements and related notes in Part I, Item 1 of this report.

 

As used in this quarterly report, the terms “we,” “us,” “our” and similar references refer to AudioEye, Inc. and our wholly-owned subsidiary, unless otherwise indicated.

 

Cautionary Note Regarding Forward-Looking Statements

 

Any statements in this Quarterly Report on Form 10-Q about our expectations, beliefs, plans, objectives, prospects, financial condition, assumptions or future events or performance are not historical facts and are “forward-looking statements” as that term is defined under the federal securities laws. These statements are often, but not always, made through the use of words or phrases such as “believe”, “anticipate”, “should”, “intend”, “plan”, “will”, “expects”, “estimates”, “projects”, “positioned”, “strategy”, “outlook” and similar words. You should read the statements that contain these types of words carefully. Such forward-looking statements are subject to a number of risks, uncertainties and other factors that could cause actual results to differ materially from what is expressed or implied in such forward-looking statements. There may be events in the future that we are not able to predict accurately or over which we have no control. Potential risks and uncertainties include, but are not limited to, those discussed in “Part I, Item 1A. Risk Factors” in our Annual Report filed on Form 10-K for the year ended December 31, 2017. We urge you not to place undue reliance on these forward-looking statements, which speak only as of the date of this report. We do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or uncertainties after the date hereof or to reflect the occurrence of unanticipated events.

 

Overview

 

AudioEye is a marketplace leader providing web accessibility solutions for our clients’ customers through our Ally Platform Products. Our technology advances accessibility with patented technology solutions that reduce barriers, expand access for individuals with disabilities, and enhance the user experience for a broader audience of users. When implemented, we believe that our solutions offer businesses the opportunity to reach more customers, improve brand image, and build additional brand loyalty.  In addition, our solutions help organizations comply with internationally accepted Web Content Accessibility Guidelines (WCAG) as well as US, Canadian, Australian, and United Kingdom accessibility laws.

 

We generate revenues through the sale of subscriptions of our software as a service (SaaS) technology platform, called the AudioEye Ally Platform, to website owners, publishers, developers, and operators and through the delivery of managed services combined with the implementation of the AudioEye solution. Our solutions have been adopted by some of the largest and most influential companies in the world. Our customers span disparate industries and target market verticals, which encompass (but are not limited to) the following categories: human resources, finance, transportation, media, and education. Government agencies have also integrated our software in their digital platforms.

 

The AudioEye Solution

 

AudioEye uses proprietary technology and development tools to offer web accessibility solutions that offer significant savings in time and money relative to traditional solutions. Our compliance solutions focus on rapid remediation of the most important accessibility issues, followed by in-depth analysis identifying and addressing a more comprehensive compliance program. Our technology was built to not only provide users with a cloud-based assistive toolset that gets embedded and made freely available to users within our client websites, but to also improve the code in a way that optimizes the user experience for users of existing third-party assistive technologies, such as screen readers.

 

 18 

 

  

Intellectual Property

 

Our technology development was initiated at the University of Arizona Science & Technology Park in Tucson, Arizona. In 2006, we received technology development venture funding from the Maryland Technology Development Corporation (TEDCO), which contributed to the development of our platform strategy. Beginning in 2009, we engaged in a multi-year technology development program with the Eller College of Management’s Department of Management Information Systems at the University of Arizona.  In connection with our proprietary technology, our company has been issued a number of U.S. patents in two distinct patent families.  Today, an experienced team of in-house engineers, designers, and developers in our Atlanta, GA, and Tucson, AZ, offices develop the Company’s technology & software and are actively engaged in the expansion of the AudioEye IP Portfolio.

 

Our patented technology was a 2013 Edison Gold Award winner for innovation in the category of “Quality of Life.”

 

Our intellectual property is primarily comprised of trade secrets, trademarks, issued and pending patents, copyrights and technological innovation. We have a patent portfolio comprised of six patents issued in the United States, we have received a notice of allowance from the U.S. Patent and Trademark Office for a seventh patent, and we have several additional patents that are either pending or are being prepared for filing in the United States and internationally.

 

Our current patented invention relates to a server-side method and apparatus that enables users to audibly navigate websites and hear high-quality streaming audio narration and descriptions of websites.  This patented invention involves creating an audio-enabled web experience by utilizing voice talent and automated text-to-speech conversion methods to read and describe web content. It involves the creation of audio files for each section within a website, and then assigning a hierarchy and navigation system in line with the website design.  To implement the system, a script is installed across the pages of the website and, when loaded, it plays an audible tone upon a user’s visit indicating that the website is enhanced with our proprietary technology.  Upon hearing the tone, a user presses a key on the keyboard to enter the audible website.  Audible narration is played through the user’s computer, reading text and describing non-text information, such as images.  The narration includes menus for navigating the site which have a hierarchy in line that of the original website.  Users navigate the website menus and move from webpage to webpage by making keystrokes or using a mouse.

 

Our current portfolio has established a foundation for building unique technology solutions that contribute to the way in which we differentiate ourselves from other competitors in the B2B Web Accessibility marketplace. We plan to continue to invest in research and development, and expand our portfolio of proprietary intellectual property.

 

Our Annual Report filed on Form 10-K for the year ended December 31, 2017 provides additional information about our business and operations.

 

Results of Operations

 

Our consolidated financial statements are stated in United States Dollars and are prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”). The discussion of the results of our operations compares the three and six months ended June 30, 2018 with the three and six months ended June 30, 2017 and are not necessarily indicative of the results which may be expected for any subsequent period.  Our prospects should be considered in light of the risks, expenses and difficulties encountered by companies in similar positions.  We may not be successful in addressing these risks and difficulties.

 

 19 

 

  

Comparative for the Three Months ended June 30, 2018 and June 30, 2017

 

Results of Operations

 

   Three Months Ended
June 30,
 
   2018   2017 
Revenue  $1,234,897   $684,224 
           
Cost of sales   622,645    440,033 
Gross profit   612,252    244,191 
Operating expenses:          
Selling & marketing   576,894    337,156 
Research & development   49,362    49,267 
General and administrative expenses   944,428    615,528 
Amortization & depreciation   137,412    147,921 
Total operating expenses   1,708,096    1,149,872 
Operating loss   (1,095,844)   (905,681)
           
Unrealized loss on derivative liabilities   -    (1,264,962)
Unrealized gain on marketable securities   1,422    - 
Interest expense   (105)   (48,284)
           
Net loss   (1,094,527)   (2,218,927)
Deemed dividend on Series A Convertible preferred stock   (13,524)   (20,000)
Net loss attributable to common stockholders  $(1,108,051)  $(2,238,927)
Net income per common share – basic and diluted   (0.17)   (0.50)
Weighted average common shares outstanding – basic and diluted   6,471,831    4,494,859 

 

Revenue

 

For the three months ended June 30, 2018 and 2017, revenue was $1,234,897 and $684,224, respectively, consisting primarily of revenues from various levels of subscriptions and technology development. Revenues increased due to a change of marketing focus.

 

Cost of Sales

 

For the three months ended June 30, 2018 and 2017, cost of sales was $622,645 and $440,033, respectively, consisting primarily of sub-contracting to outside sources, direct labor and direct technology costs.

 

Gross Profit

 

An increase in our revenues resulted in a gross profit of $612,252 for the current period, as compared to a gross profit of $244,191 during the three months ended June 30, 2017. Gross profit increased as a result of lower implementation costs as compared to the same period in 2017.

 

Selling and Marketing Expenses

 

Selling and marketing expenses were $576,894 and $337,156 for the three months ended June 30, 2018 and 2017, respectively.  The increase resulted from the higher sales activity in 2018 as compared to 2017.

 

 20 

 

  

Research and Development Expenses

 

Research and development expenses were $49,362 and $49,267 for three months ended June 30, 2018 and 2017, respectively. Research and development expenses increased from period to period and reflect continued developments of our product.

 

General and Administrative Expenses

 

General and administrative expenses were $944,428 and $615,528 for the three months ended June 30, 2018 and 2017, respectively. General and administrative expenses increased $328,900 due primarily to higher service provider costs as compared to 2017. Stock based compensation for the three months ended June 30, 2018 was $270,722 as compared to $279,478 for the same period last year.

 

Amortization and Depreciation

 

Amortization and depreciation expenses were $137,412 and $147,921 for the three months ended June 30, 2018 and 2017, respectively. The decrease in expense was primarily related to expiring software development costs in 2017.

 

Gain on change in Fair Value of Derivative Liabilities

 

In October 2015, 2016 and 2017, we issued warrants with an embedded reset provision requiring us to fair value the derivatives each reporting period and mark to market as a non-cash adjustment to our current period operations. This resulted in a loss of $1,264,962 on change in fair value of derivative liabilities for the three months ended June 30, 2017. The primary driver of the change in our derivative liability is our stock price. Generally, as our stock price increases, the liability increases resulting in a larger non-cash loss for the period to period change.

 

On January 1, 2018, we adopted ASU 2017-11 by electing the retrospective method to the outstanding financial instruments with a down round feature by means of a cumulative-effect adjustment to the statement of financial position as of the beginning of the fiscal year. Accordingly, we are no longer required to treat as derivatives our financial instruments with embedded anti-dilutive (reset) provisions.

 

Interest Expense, net

 

Interest expense, net during the three months ended June 30, 2018 was $105 compared to $48,284 for the three months ended June 30, 2017. In 2018, we incurred interest expenses relating to our capital leases for equipment as compared to non-cash interest expense and debt discounts relating to our convertible note payable of $39,644 and $7,326 in 2017, respectively.

 

 21 

 

  

Comparative for the Six Months ended June 30, 2018 and June 30, 2017

 

Results of Operations

 

   Six Months Ended
June 30,
 
   2018   2017 
Revenue  $2,384,239   $1,118,731 
           
Cost of sales   1,210,109    781,075 
Gross profit   1,174,130    337,656 
Operating expenses:          
Selling & marketing   1,187,556    616,883 
Research & development   99,029    93,969 
General and administrative expenses   1,881,388    1,353,209 
Amortization & depreciation   265,077    293,409 
Total operating expenses   3,433,050    2,357,470 
Operating loss   (2,258,920)   (2,019,814)
           
Unrealized loss on derivative liabilities   -    (954,189)
Unrealized gain on marketable securities   1,650    - 
Interest income (expense), net   132    (48,120)
           
Net loss   (2,257,138)   (3,022,123)
Deemed dividend on Series A Convertible preferred stock   (27,274)   (40,000)
Net loss attributable to common stockholders  $(2,284,412)  $(3,062,123)
Net income per common share – basic and diluted   (0.35)   (0.68)
Weighted average common shares outstanding – basic and diluted   6,469,212    4,485,164 

 

Revenue

 

For the six months ended June 30, 2018 and 2017, revenue was $2,384,239 and $1,118,731, respectively, consisting primarily of revenues from various levels of subscriptions and technology development. Revenues increased due to a change of marketing focus.

 

Cost of Sales

 

For the six months ended June 30, 2018 and 2017, cost of sales was $1,210,109 and $781,075, respectively, consisting primarily of sub-contracting to outside sources, direct labor and direct technology costs.

 

Gross Profit

 

An increase in our revenues resulted in a gross profit of $1,174,130 for the current period, as compared to a gross profit of $337,656 during the six months ended June 30, 2017. Gross profit increased as a result of lower implementation costs as compared to the same period in 2017.

 

Selling and Marketing Expenses

 

Selling and marketing expenses were $1,187,556 and $616,883 for the six months ended June 30, 2018 and 2017, respectively.  The increase resulted from the higher sales activity in 2018 as compared to 2017.

 

 22 

 

  

Research and Development Expenses

 

Research and development expenses were $99,029 and $93,969 for six months ended June 30, 2018 and 2017, respectively. Research and development expenses increased from period to period and reflect continued developments of our product.

 

General and Administrative Expenses

 

General and administrative expenses were $1,881,388 and $1,353,209 for the six months ended June 30, 2018 and 2017, respectively. General and administrative expenses increased $528,179 due primarily to higher service provider costs as compared to 2017. Stock based compensation for the six months ended June 30, 2018 was $638,025 as compared to $596,317 for the same period last year.

 

Amortization and Depreciation

 

Amortization and depreciation expenses were $265,077 and $293,409 for the six months ended June 30, 2018 and 2017, respectively. The decrease in expense was primarily related to expiring software development costs in 2017.

 

Gain on change in Fair Value of Derivative Liabilities

 

In October 2015, 2016 and 2017, we issued warrants with an embedded reset provision requiring us to fair value the derivatives each reporting period and mark to market as a non-cash adjustment to our current period operations. This resulted in a loss of $954,189 on change in fair value of derivative liabilities for the six months ended June 30, 2017. The primary driver of the change in our derivative liability is our stock price. Generally, as our stock price increases, the liability increases resulting in a larger non-cash loss for the period to period change.

 

On January 1, 2018, we adopted ASU 2017-11 by electing the retrospective method to the outstanding financial instruments with a down round feature by means of a cumulative-effect adjustment to the statement of financial position as of the beginning of the fiscal year. Accordingly, we are no longer required to treat as derivatives our financial instruments with embedded anti-dilutive (reset) provisions.

 

Interest Income, net

 

Interest income, net during the six months ended June 30, 2018 was $132 compared to $(48,120) interest expense for the six months ended June 30, 2017. In 2017, we incurred non-cash interest expense and debt discount amortization related to our convertible note payable of $39,644 and $6,326, respectively.

 

Contracts in Process/Revenue Recognition

 

Under current accounting procedures, the Company only recognizes revenue on new contracts for the actual services delivered in the period under the following criteria: (i) the contract has been signed and delivered to the Company; (ii) the services have been performed or delivered; and (iii) the client has been billed for the services delivered. The Company does not record deferred revenues for new contracts until the first payment for services has been received. The Company only records accounts receivable for the amount of revenue recognized as service is rendered, even if the client has been billed for the entire contract value. The table below summarizes the amount of contract value in excess of the revenue recognized of $5,447,838, our deferred revenue of $1,697,266 and amount recognized in the amount of $2,384,239 in 2018. Contract and deferred revenues are expected to be recognized in future periods. The Company also receives contracts for service hours but whose total contract value is uncertain. These “fee for service contracts” are recorded in the table below only if the services have been delivered and the associated revenue has been recognized.

 

 23 

 

  

A summary of our contracts in process is as follows:

 

   Contracts in Process 
   June 30, 2018 
       Revenue   Revenue
Recognized
   Deferred   Contract Amount in
Excess of Deferred
 
   Contract   Recognized   6 Months Ended   Revenue   Revenue and 
   Amount   prior to 2018   June 30, 2018   June 30, 2018   Recognized Revenue 
Fixed Contracts  $11,721,179   $2,191,836   $2,384,239   $1,697,266   $5,447,838 

 

Liquidity and Capital Resources

 

Working Capital

 

   At June 30,   At December 31, 
   2018   2017 
Current Assets  $1,069,518   $2,134,403 
Current Liabilities   1,819,859    4,333,329 
Working Capital (Deficit)  $(750,341)  $(2,198,926)

 

The working capital (deficit) (current liabilities in excess of current assets) for the periods ended June30, 2018 and December 31, 2017 was $(750,341) and $(2,198,926) respectively. The increase in working capital was primarily due to increase in our accounts receivable of $151,916, in our deferred costs of $61,221, elimination of liability treatment of our previously issued anti-dilutive warrants of $2,984,010 and a decrease in accounts payable and accrued expenses of $6,940, net with increases in our deferred revenue of $463,512 and short term portion of our capital leases of $19,110. In addition, the Company used actual net cash in operations of $1,094,896 during the six months ended June 30, 2018. 

 

On August 6, 2018, the Company sold 992,000 shares of its common stock at $6.25 per share for net proceeds of $5,547,635, after costs and expenses of $652,365. In addition, the Company has received common stock subscriptions for 48,000 shares of its common stock at a sales price of $6.25 per share for net proceeds of $288,000, after costs and expenses of $12,000. It is anticipated that the Company has cash sufficient to fund operations for the next twelve months.

 

Cash Flows

 

   For the Six
months ended
 
   June 30, 
   2018   2017 
         
Net Cash (Used in) Operating Activities  $(1,094,896)  $(1,021,316)
Net Cash (Used in) Investing Activities   (184,490)   (67,225)
Net Cash (Used in) Provided by Financing Activities   (1,454)   88,000 
Decrease in Cash  $(1,280,840)  $(1,000,541)

 

We had cash in the amount of $679,590 and $1,960,430 as of June 30, 2018 and December 31, 2017, respectively.

 

 24 

 

  

Critical Accounting Policies

 

The discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with the accounting principles generally accepted in the United States. Preparing financial statements requires our management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, and expenses. These estimates and assumptions are affected by our management’s application of accounting policies. We believe that understanding the basis and nature of the estimates and assumptions involved with the following aspects of our financial statements is critical to an understanding of our financial statements.

 

Our critical accounting policies, as described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, relate to capitalized legal patent costs, income taxes, goodwill, intangible assets, share-based payments, revenue recognition, and research and other accounting descriptions. There have been no material changes to our critical accounting policies as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

As required under Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), we carried out an evaluation under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2018. Based upon that evaluation, the Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures as of June 30, 2018 were not effective, for the same reasons as previously disclosed under Item 9A. “Controls and Procedures” in our Annual Report on Form 10-K for our fiscal year ended December 31, 2017.

 

Changes in Internal Controls over Financial Reporting

 

There have been no changes in our internal controls over financial reporting (as defined in Rule 13a-15(f) and 15d-(f) of the Exchange Act) that occurred during the our last fiscal quarter to which this report relates that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

PART II — OTHER INFORMATION

 

Item 1. Legal Proceedings

 

On January 23, 2017, the court granted preliminary approval of the settlement pursuant to the terms set forth in the Stipulation of Settlement, provisionally certified a settlement class of shareholders, and directed plaintiffs' counsel to provide notice to that class. The Court held a Settlement Hearing May 8, 2017 to consider any objections to the Settlement that might be raised by settlement class members, to consider plaintiffs’ counsel's application for an award of fees and costs, and to determine whether the Order and Final Judgment as provided under the Stipulation of Settlement should be entered, dismissing the case with prejudice. On May 8, 2017, this Court granted final approval to the settlement of the securities class action brought by Lead Plaintiffs, individually and on behalf of all others similarly situated. On February 9, 2018, the Court authorized distribution of the Net Settlement Fund and approved the proposed modified plan of allocation.

 

 25 

 

  

On May 16, 2016, a shareholder derivative complaint entitled LiPoChing, Derivatively and on Behalf of AudioEye, Inc., v. Bradley, et al., was filed in the United States District Court for the District of Arizona. As a derivative complaint, the plaintiff-shareholder purported to act on behalf of the Company against the Named Individuals. The Company was named as a nominal defendant. The complaint asserted causes of action including breach of fiduciary duty and others, arising from the Company’s restatement of its financial results for the first three quarters of 2014. The complaint sought, among other relief, compensatory damages, restitution and attorneys’ fees. In October 2016, the Company and Named Defendants filed a motion to dismiss. In response, the Plaintiff voluntarily dismissed the complaint without prejudice. Plaintiff’s counsel subsequently submitted a demand to the Company’s Board of Directors, to investigate the circumstances surrounding restatement of its financial results for the first three quarters of 2014. On June 22, 2018, the matter was resolved to the parties’ satisfaction. The resolution of the matter will not have a material adverse effect on our financial position or results of operations.

 

On July 26, 2016, a shareholder derivative complaint entitled Denese M. Hebert, derivatively on Behalf of Nominal Defendant AudioEye, Inc., v. Bradley, et al., was filed in the State of Arizona Superior Court for Pima County. The complaint generally asserted causes of action related to the Company’s restatement of its financial statements for the first three fiscal quarters of 2014. As a derivative complaint, the plaintiff-shareholder purported to act on behalf of the Company against the Named Individuals. The Company was named as a nominal defendant. The defendants filed a motion to dismiss, which the Court granted on May 8, 2017, while also denying Plaintiff’s request for leave to amend the complaint. As in the above matter, after this matter was dismissed Plaintiff’s counsel subsequently submitted a demand to the Company’s Board of Directors, to investigate the circumstances surrounding restatement of its financial results for the first three quarters of 2014. On June 22, 2018, the matter was resolved to the parties’ satisfaction. The resolution of the matter will not have a material adverse effect on our financial position or results of operations.

 

We may become involved in various other routine disputes and allegations incidental to our business operations. While it is not possible to determine the ultimate disposition of these matters, our management believes that the resolution of any such matters, should they arise, is not likely to have a material adverse effect on our financial position or results of operations.

 

Item 1A. Risk Factors

 

There have been no material changes from the risk factors disclosed in Item 1.A of Part I of our Annual Report on Form 10-K for the year ended December 31, 2016.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

None.

 

Item 5. Other Information

 

None.

 

 26 

 

  

Item 6. Exhibits

 

Exhibit
No.
  Description
31.1*   Certification of the Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1*   Certification of the Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS*   XBRL Instance Document
     
101.SCH*   XBRL Taxonomy Extension Schema Document
     
101.CAL*   XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF*   XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB*   XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE*   XBRL Taxonomy Extension Presentation Linkbase Document

 

*Filed herewith.

 

 27 

 

  

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized on the 14th day of August, 2018.

 

  AUDIOEYE, INC.
     
  By:   /s/ Dr. Carr Bettis
    Dr. Carr Bettis
    Principal Executive Officer
     
  By: /s/ Todd Bankofier
    Todd Bankofier
    Chief Executive Officer

 

 28